Analysis of an FDA data base has revealed that commonly prescribed depression and high cholesterol drugs may raise blood sugar levels if taken together. This previously undiscovered effect on blood glucose has important implications for diabetics and those at risk of developing diabetes.
The data mining revealed an unexpected spike in blood sugar in patients talking both the antidepressant Paxil (paroxetine) and the cholesterol drug Pravachol (pravastatin). An estimated up to one million Americans are taking the two drugs, many of them diabetics.
“If a physician has a patient on these [two] medications and their diabetes becomes harder to control, the physician may want to consider changing the medications,” said the study’s principal investigator, Stanford University professor Dr. Russ Altman.
To read more about the implications of this possibly harmful interaction on glucose metabolism and diabetes control on InformationWeek, >CLICK HERE.<
RSS